Clinical Trial Update: Effects of Low-dose Naltrexone in Combination With a Range of Smoked Marijuana [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating low-dose naltrexone in combination with smoked marijuana, completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marijuana Use Disorder

Drugs mentioned

• Marijuana
• Naltrexone (low-dose) (naltrexone)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Marijuana Smoking | Phase 2 | Status: COMPLETED | Results posted: 2018-09-14